Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® [Phase 3]
Phase 3 trial comparing GlaxoSmithKline's reduced antigen DTaP-IPV vaccine to Boostrix and standalone or Revaxis-administered IPV in tetanus…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. [Phase 4]
This Phase 4 trial update evaluates immunogenicity, antibody persistence, and safety of GSK's DTPa INFANRIX and dTpa BOOSTRIX vaccines; the …
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Seroepidemiological Study of Pertussis and Other Infectious Diseases
Completed seroepidemiological study of pertussis and other infectious diseases. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
Completed descriptive post-marketing safety study of the ADACEL vaccine (Tdap) monitoring adverse events under passive surveillance for pert…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Study of Adacel® Vaccine Administered to Persons 10 Years of Age [Phase 4]
Phase 4 clinical trial of the Adacel vaccine in 10-year-olds with results posted, evaluating safety and immunogenicity against tetanus, diph…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice [NA]
A completed clinical trial evaluating how the clinical tool 'What’s Going Around' influences practice for influenza-like illness, asthma, Gr…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) [Phase 1]
Phase 1 persistency study of aP/Tdap booster vaccines in adults completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Protecting Pregnant Women From Infectious Diseases [NA]
Completed clinical trial update from Emory University on protecting pregnant women from influenza and pertussis.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Duration of Protection: GSK DTaP Vaccines
A completed clinical trial from GlaxoSmithKline evaluated the duration of protection provided by GSK's DTaP vaccine against diphtheria, teta…
-
CLINICAL_TRIALS withdrawal · 2015-10-09Clinical Trial Update: A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) [Phase 3]
A Phase 3 study evaluating immunogenicity and safety of a whole-cell pertussis–containing vaccine given with Rotarix or RotaTeq has been wit…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old [Phase 3]
Phase 3 trial comparing intramuscular SP306 to subcutaneous DT in Japanese adolescents aged 11-12 evaluating vaccines for tetanus, diphtheri…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Database Surveillance Safety Study of PENTACEL® Vaccine
Completed database surveillance safety study evaluating the Pentacel vaccine for safety signals related to its diphtheria, tetanus, pertussi…
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India [NA]
A clinical trial update notes the Khushi Baby mobile health solution for vaccination record keeping in India, focusing on the DTP vaccine se…
-
CLINICAL_TRIALS research · 2015-07-28Clinical Trial Update: Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates [Phase 4]
Phase 4 clinical trial update from a French hospital on an immunisation schedule combining diphtheria, tetanus, poliomyelitis with Pertussis…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
GlaxoSmithKline-sponsored trial examining risk factors for pertussis infection among infants has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants [Phase 3]
Phase 3 study completion update for an adsorbed DTaP vaccine in healthy 3- to 5-month-old infants tested for pertussis.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…